|
1.
|
Sinal CJ and Gonzalez FJ: Guggulsterone:
an old approach to a new problem. Trends Endocrinol Metab.
13:275–276. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Urizar NL and Moore DD: GUGULIPID: a
natural cholesterol-lowering agent. Annu Rev Nutr. 23:303–313.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Yang JY, Della-Fera MA and Baile CA:
Guggulsterone inhibits adipocyte differentiation and induces
apoptosis in 3T3-L1 cells. Obesity (Silver Spring). 16:16–22. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Shishodia S, Sethi G, Ahn KS and Aggarwal
BB: Guggulsterone inhibits tumor cell proliferation, induces
S-phase arrest, and promotes apoptosis through activation of c-Jun
N-terminal kinase, suppression of Akt pathway, and downregulation
of antiapoptotic gene products. Biochem Pharmacol. 74:118–130.
2007. View Article : Google Scholar
|
|
5.
|
Satyavati GV: Gum guggul (Commiphora
mukul) - the success story of an ancient insight leading to a
modern discovery. Indian J Med Res. 87:327–335. 1988.PubMed/NCBI
|
|
6.
|
Shishodia S and Aggarwal BB: Guggulsterone
inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses
expression of anti-apoptotic gene products, and enhances apoptosis.
J Biol Chem. 279:47148–47158. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Cheon JH, Kim JS, Kim JM, Kim N, Jung HC
and Song IS: Plant sterol guggulsterone inhibits nuclear
factor-kappaB signaling in intestinal epithelial cells by blocking
IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel
Dis. 12:1152–1161. 2006. View Article : Google Scholar
|
|
8.
|
Ichikawa H and Aggarwal BB: Guggulsterone
inhibits osteoclastogenesis induced by receptor activator of
nuclear factor-kappaB ligand and by tumor cells by suppressing
nuclear factor-kappaB activation. Clin Cancer Res. 12:662–668.
2006. View Article : Google Scholar
|
|
9.
|
Woessner JF Jr: Matrix metalloproteinases
and their inhibitors in connective tissue remodeling. FASEB J.
5:2145–2154. 1991.PubMed/NCBI
|
|
10.
|
Nakajima M, Welch DR, Belloni PN and
Nicolson GL: Degradation of basement membrane type IV collagen and
lung subendothelial matrix by rat mammary adenocarcinoma cell
clones of differing metastatic potentials. Cancer Res.
47:4869–4876. 1987.PubMed/NCBI
|
|
11.
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Saito N, Hatori T, Murata N, et al: A
double three-step theory of brain metastasis in mice: the role of
the pia mater and matrix metalloproteinases. Neuropathol Appl
Neurobiol. 33:288–298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Castellano G, Malaponte G, Mazzarino MC,
et al: Activation of the osteopontin/matrix metalloproteinase-9
pathway correlates with prostate cancer progression. Clin Cancer
Res. 14:7470–7480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kanayama H: Matrix metalloproteinases and
bladder cancer. J Med Invest. 48:31–43. 2001.PubMed/NCBI
|
|
15.
|
Lin CW, Hou WC, Shen SC, et al: Quercetin
inhibition of tumor invasion via suppressing PKC
delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in
breast carcinoma cells. Carcinogenesis. 29:1807–1815. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lee SO, Jeong YJ, Kim M, Kim CH and Lee
IS: Suppression of PMA-induced tumor cell invasion by capillarisin
via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem
Biophys Res Commun. 366:1019–1024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Yao J, Xiong S, Klos K, et al: Multiple
signaling pathways involved in activation of matrix
metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast
cancer cells. Oncogene. 20:8066–8074. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Ruhul Amin AR, Senga T, Oo ML, Thant AA
and Hamaguchi M: Secretion of matrix metalloproteinase-9 by the
proinflammatory cytokine, IL-1beta: a role for the dual signalling
pathways, Akt and Erk. Genes Cells. 8:515–523. 2003.PubMed/NCBI
|
|
19.
|
Karin M: The regulation of AP-1 activity
by mitogen-activated protein kinases. J Biol Chem. 270:16483–16486.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Madrid LV, Mayo MW, Reuther JY and Baldwin
AS Jr: Akt stimulates the transactivation potential of the RelA/p65
Subunit of NF-kappa B through utilization of the Ikappa B kinase
and activation of the mitogen-activated protein kinase p38. J Biol
Chem. 276:18934–18940. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Weng CJ, Chau CF, Hsieh YS, Yang SF and
Yen GC: Lucidenic acid inhibits PMA-induced invasion of human
hepatoma cells through inactivating MAPK/ERK signal transduction
pathway and reducing binding activities of NF-kappaB and AP-1.
Carcinogenesis. 29:147–156. 2008. View Article : Google Scholar
|
|
22.
|
Nabeshima K, Inoue T, Shimao Y and
Sameshima T: Matrix metalloproteinases in tumor invasion: role for
cell migration. Pathol Int. 52:255–264. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Hong S, Park KK, Magae J, et al:
Ascochlorin inhibits matrix metalloproteinase-9 expression by
suppressing activator protein-1-mediated gene expression through
the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on
the invasion of renal carcinoma cells. J Biol Chem.
280:25202–25209. 2005. View Article : Google Scholar
|
|
24.
|
Woo MS, Jung SH, Kim SY, et al: Curcumin
suppresses phorbol ester-induced matrix metalloproteinase-9
expression by inhibiting the PKC to MAPK signaling pathways in
human astroglioma cells. Biochem Biophys Res Commun. 335:1017–1025.
2005. View Article : Google Scholar
|
|
25.
|
Kim KH, Park BH, Tu Y, et al:
Polarization-sensitive optical frequency domain imaging based on
unpolarized light. Opt Express. 19:552–561. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Plumb JA, Milroy R and Kaye SB: Effects of
the pH dependence of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium
bromide-formazan absorption on chemosensitivity determined by a
novel tetrazolium-based assay. Cancer Res. 49:4435–4440. 1989.
|
|
27.
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Azuma M, Aota K, Tamatani T, et al:
Suppression of tumor necrosis factor alpha-induced matrix
metalloproteinase 9 production in human salivary gland acinar cells
by cepharanthine occurs via down-regulation of nuclear factor
kappaB: a possible therapeutic agent for preventing the destruction
of the acinar structure in the salivary glands of Sjogren’s
syndrome patients. Arthritis Rheum. 46:1585–1594. 2002.
|
|
29.
|
Hwang YP, Yun HJ, Kim HG, Han EH, Lee GW
and Jeong HG: Suppression of PMA-induced tumor cell invasion by
dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and
NF-kappaB/AP-1-dependent mechanisms. Biochem Pharmacol.
79:1714–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Eberhardt W, Huwiler A, Beck KF, Walpen S
and Pfeilschifter J: Amplification of IL-1 beta-induced matrix
metalloproteinase-9 expression by superoxide in rat glomerular
mesangial cells is mediated by increased activities of NF-kappaB
and activating protein-1 and involves activation of the
mitogen-activated protein kinase pathways. J Immunol.
165:5788–5797. 2000.
|
|
31.
|
Lungu G, Covaleda L, Mendes O,
Martini-Stoica H and Stoica G: FGF-1-induced matrix
metalloproteinase-9 expression in breast cancer cells is mediated
by increased activities of NF-kappaB and activating protein-1. Mol
Carcinog. 47:424–435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Yamamoto Y and Gaynor RB: Therapeutic
potential of inhibition of the NF-kappaB pathway in the treatment
of inflammation and cancer. J Clin Invest. 107:135–142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Thanos D and Maniatis T: NF-kappa B: a
lesson in family values. Cell. 80:529–532. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Chung TW, Moon SK, Chang YC, et al: Novel
and therapeutic effect of caffeic acid and caffeic acid phenyl
ester on hepatocarcinoma cells: complete regression of hepatoma
growth and metastasis by dual mechanism. FASEB J. 18:1670–1681.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Bakiri L, Matsuo K, Wisniewska M, Wagner
EF and Yaniv M: Promoter specificity and biological activity of
tethered AP-1 dimers. Mol Cell Biol. 22:4952–4964. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Scorilas A, Karameris A, Arnogiannaki N,
et al: Overexpression of matrix-metalloproteinase-9 in human breast
cancer: a potential favourable indicator in node-negative patients.
Br J Cancer. 84:1488–1496. 2001. View Article : Google Scholar : PubMed/NCBI
|
